bibliographicCitation |
Belur Nagaraj A, Joseph P, Kovalenko O, Wang Q, Xu R, DiFeo A. Evaluating class III antiarrhythmic agents as novel MYC targeting drugs in ovarian cancer. Gynecologic Oncology. 2018 Dec;151(3):525–32. doi: 10.1016/j.ygyno.2018.09.019. |